朴素幼晴
Lv3
360 积分
2023-05-06 加入
-
Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab‐naïve relapsed multiple myeloma
5天前
已完结
-
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
5天前
已完结
-
Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis
11天前
已完结
-
Complete response and survival outcomes in patients with advanced cancer on immune checkpoint inhibitors
11天前
已完结
-
The role of precision nutrition in the modulation of microbial composition and function in people with inflammatory bowel disease
18天前
已完结
-
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
18天前
已完结
-
A comparison of pregnancy rates following fresh and frozen embryo transfer according to the use of leuprolide acetate vs ganirelix vs cetrorelix
19天前
已完结
-
Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment
21天前
已完结
-
End-stage organ disease–Healthcare utilisation: Impact of palliative medicine
24天前
已完结
-
Bone metastases
25天前
已完结